Strategic Wealth Investment Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,530
| Closed | -$47.3K | – | 135 |
|
|
2023
Q1 | $47.3K | Hold |
31,530
| – | – | 0.01% | 129 |
|
|
2022
Q4 | $45.7K | Sell |
31,530
-5,478
| -15% | -$7.94K | 0.01% | 119 |
|
|
2022
Q3 | $42K | Sell |
37,008
-12,728
| -26% | -$14.4K | 0.01% | 110 |
|
|
2022
Q2 | $79K | Sell |
49,736
-12,752
| -20% | -$20.3K | 0.02% | 130 |
|
|
2022
Q1 | $96K | Sell |
62,488
-2,581
| -4% | -$3.97K | 0.02% | 99 |
|
|
2021
Q4 | $159K | Sell |
65,069
-5,556
| -8% | -$13.6K | 0.04% | 84 |
|
|
2021
Q3 | $179K | Buy |
70,625
+6,393
| +10% | +$16.2K | 0.05% | 81 |
|
|
2021
Q2 | $183K | Sell |
64,232
-382
| -0.6% | -$1.09K | 0.06% | 82 |
|
|
2021
Q1 | $152K | Sell |
64,614
-2,303
| -3% | -$5.42K | 0.07% | 72 |
|
|
2020
Q4 | $118K | Sell |
66,917
-2,957
| -4% | -$5.21K | 0.07% | 76 |
|
|
2020
Q3 | $65K | Buy |
69,874
+10,277
| +17% | +$9.56K | 0.05% | 82 |
|
|
2020
Q2 | $52K | Buy |
+59,597
| New | +$52K | 0.05% | 78 |
|